CoMSIA/QSAR Models for Vacuolar (H+) ATPase Inhibition by Selected Benzoate and Benzolactone Species

Author(s): Burchelle Blackman, Gunda I. Georg, Gerald H. Lushington.

Journal Name: Letters in Drug Design & Discovery

Volume 3 , Issue 2 , 2006

Become EABM
Become Reviewer


Our CoMSIA model for benzoate and benzolactone mammalian vacuolar type (H+) ATPase inhibitors correlates well with bovine ATPase IC50 data (R2=0.968; Q2=0.553) and reliably predicts human kidney VATPase inhibition by lobatamide compounds (R=0.862). Accurately modeling oximidines (structurally underrepresented in the training set) requires perturbing the model with non-CoMSIA QSAR descriptors.

Keywords: V-ATPase, benzolactone, benzoate, CoMSIA, QSAR, molecular modeling

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [104 - 107]
Pages: 4
DOI: 10.2174/157018006775789748
Price: $65

Article Metrics

PDF: 1